Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery

Summary

Severe obesity is associated with considerable reduction of wellbeing and life expectancy. People living with severe obesity tend to die 8 to 10 years earlier. Preoperative management of patients living with severe obesity can be challenging and proper weight-loss may help obtain better outcomes and less morbidity. The effectiveness of GLP-1 analogue Liraglutide in preoperative weight-loss was evaluated in the study.

Timeline

Start

2022-12-18

Primary completion

2023-03-18

Completion

2023-05-01

Drugs

Indications